abstract |
The present invention relates to novel pyridines useful as SHP2 inhibitors Derivatives (as shown in structural formula I), their synthetic methods, and treatment, prevention or prevention of diseases or disorders by SHP2 active vectors. Further, the present invention relates to a fusion heterocyclic derivative used as an SHP2 inhibitor, and a method for preparing the same, and a method for treating, preventing or preventing a disease or discomfort from an SHP2 active vector. |